Cargando…
Agranulocytosis associated with aminoglutethimide: pharmacological and marrow studies.
Autores principales: | Harris, A. L., Hughes, G., Barrett, A. J., Abusrewil, S., Dowsett, M., Smith, I. E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001657/ https://www.ncbi.nlm.nih.gov/pubmed/3730249 |
Ejemplares similares
-
Role of aminoglutethimide in male breast cancer.
por: Harris, A. L., et al.
Publicado: (1986) -
Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.
por: Dowsett, M., et al.
Publicado: (1984) -
Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1983) -
Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1983) -
A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.
por: Dowsett, M., et al.
Publicado: (1985)